Infinifluidics Inc. received a $256,000 National Science Foundation Project Grant under the Engineering (47.041) federal grant program. The grant supports development of on-demand continuous and sterile manufacturing of injectable drug delivery systems at industrial scale on a portable microfluidic chip from July 1, 2021 to June 30, 2022. The Engineering program seeks to improve quality of life and economic strength through innovative engineering research and education. This award will allow Infinifluidics to advance on-site production of sterile injectable medications using their microfluidic technology, helping facilitate continuous manufacturing approaches at scale for drug delivery systems.
Generated 1/7/24, 10:19 AM